Targeted therapy of lymphatic vessels and microvasculature in the metabolic syndrome with myocardial insufficiency and preserved heart ejection fraction

The aim is to understand the pathogenesis and pathophysiology of MetS-related HF according to age and sex in different experimental animal models and patients.